Your search returned 3 results.

Results
	1.	Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients. [electronic resource] by Smith, John W Vukelja, Svetislava Rabe, Amy Wentworth-Hartung, Nicole Koutrelakos, Nicholas Shao, Spencer H Whittaker, Thomas Wang, Yunfei Asmar, Lina McDowell, Diane Opatt Mukhopadhyay, Pralay O'Shaughnessy, Joyce Producer: 20140814 In: Breast cancer research and treatment vol. 142 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary. [electronic resource] by Palma, Norma A Ali, Siraj M O'Connor, Jamie Dutta, Deepa Wang, Kai Soman, Salil Palmer, Gary A Morosini, Deborah Ross, Jeffrey S Lipson, Doron Stephens, Phil J Patel, Mayur Miller, Vincent A Koutrelakos, Nicholas Producer: 20140918 In: Case reports in oncology vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer. [electronic resource] by Osborne, Cynthia Challagalla, Jagathi D Eisenbeis, Charles F Holmes, Frankie Ann Neubauer, Marcus A Koutrelakos, Nicholas W Taboada, Carlos A Vukelja, Sasha J Wilks, Sharon T Allison, Mary Ann Reddy, Praveen Sedlacek, Scot Wang, Yunfei Asmar, Lina O'Shaughnessy, Joyce Producer: 20190319 In: Clinical breast cancer vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)